INTEGRA LIFESCIENCES HOLDINGS CORP Excess Tax Benefit from Share-based Compensation, Operating Activities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $1.81 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-04-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2016-04-27
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was $1.81M, a 61.28% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-12-31 was $114.00K, a 35.59% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-09-30 was $177.00K, a 311.63% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-06-30 was $2.38M, a 282.02% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $3.79M, a 173.99% increase from fiscal 2014.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $1.38M, a 412.59% increase from fiscal 2013.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $270.00K, a 92.57% decline from fiscal 2012.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $3.63M.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|
| 2016-03-31 | $1.81M 10-Q · filed 2016-04-27 | $1.92M derived: sum of 2 quarters · filed 2016-04-27 | $2.10M derived: sum of 3 quarters · filed 2016-04-27 | $4.48M derived: sum of 4 quarters · filed 2016-04-27 |
| 2015-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $291.00K derived: sum of 2 quarters · filed 2016-02-26 | $2.67M derived: sum of 3 quarters · filed 2016-02-26 | $3.79M 10-K · filed 2016-02-26 |
| 2015-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.56M derived: sum of 2 quarters · filed 2015-11-04 | $3.68M 10-Q · filed 2015-11-04 | $3.85M derived: sum of 4 quarters · filed 2016-04-27 |
| 2015-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $3.50M 10-Q · filed 2015-07-31 | $3.68M derived: sum of 3 quarters · filed 2016-04-27 | $3.72M derived: sum of 4 quarters · filed 2016-04-27 |
| 2015-03-31 | $1.12M 10-Q · filed 2016-04-27 | $1.30M derived: sum of 2 quarters · filed 2016-04-27 | $1.34M derived: sum of 3 quarters · filed 2016-04-27 | $1.96M derived: sum of 4 quarters · filed 2016-04-27 |
| 2014-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $220.00K derived: sum of 2 quarters · filed 2016-02-26 | $843.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.38M 10-K · filed 2016-02-26 |
| 2014-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $666.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.21M 10-Q · filed 2015-11-04 | $1.34M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $623.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.16M 10-Q · filed 2015-07-31 | $1.29M derived: sum of 3 quarters · filed 2016-02-26 | $1.33M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $541.00K 10-Q · filed 2015-05-01 | $671.00K derived: sum of 2 quarters · filed 2016-02-26 | $709.00K derived: sum of 3 quarters · filed 2016-02-26 | $788.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $168.00K derived: sum of 2 quarters · filed 2016-02-26 | $247.00K derived: sum of 3 quarters · filed 2016-02-26 | $270.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $117.00K derived: sum of 2 quarters · filed 2014-11-07 | $140.00K 10-Q · filed 2014-11-07 | $3.34M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $102.00K 10-Q · filed 2014-08-05 | $3.30M derived: sum of 3 quarters · filed 2015-02-27 | $3.32M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $23.00K 10-Q · filed 2014-05-01 | $3.23M derived: sum of 2 quarters · filed 2015-02-27 | $3.24M derived: sum of 3 quarters · filed 2015-02-27 | $3.65M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $3.22M derived: sum of 2 quarters · filed 2015-02-27 | $3.63M derived: sum of 3 quarters · filed 2015-02-27 | $3.63M 10-K · filed 2015-02-27 |
| 2012-09-30 | $14.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $429.00K derived: sum of 2 quarters · filed 2013-10-30 | $432.00K 10-Q · filed 2013-10-30 | $436.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-06-30 | $415.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $418.00K 10-Q/A · filed 2013-08-02 | $422.00K derived: sum of 3 quarters · filed 2014-06-20 | $488.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-03-31 | $3.00K 10-Q · filed 2013-05-02 | $7.00K derived: sum of 2 quarters · filed 2014-06-20 | $73.00K derived: sum of 3 quarters · filed 2014-06-20 | $798.00K derived: sum of 4 quarters · filed 2014-06-20 |
| 2011-12-31 | $4.00K derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $70.00K derived: sum of 2 quarters · filed 2014-06-20 | $795.00K derived: sum of 3 quarters · filed 2014-06-20 | $848.00K 8-K · filed 2014-06-20 |
| 2011-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $791.00K derived: sum of 2 quarters · filed 2012-10-24 | $844.00K 10-Q · filed 2012-10-24 | $949.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $778.00K 10-Q · filed 2012-07-31 | $883.00K derived: sum of 3 quarters · filed 2013-02-26 | $884.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $53.00K 10-Q · filed 2012-04-26 | $158.00K derived: sum of 2 quarters · filed 2013-02-26 | $159.00K derived: sum of 3 quarters · filed 2013-02-26 | $721.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $106.00K derived: sum of 2 quarters · filed 2013-02-26 | $668.00K derived: sum of 3 quarters · filed 2013-02-26 | $3.58M 10-K · filed 2013-02-26 |
| 2010-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $563.00K derived: sum of 2 quarters · filed 2011-10-31 | $3.48M 10-Q · filed 2011-10-31 | $3.48M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $3.47M 10-Q · filed 2011-08-01 | $3.48M derived: sum of 3 quarters · filed 2012-02-27 | $3.49M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $2.91M 10-Q · filed 2011-04-28 | $2.92M derived: sum of 2 quarters · filed 2012-02-27 | $2.92M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $13.00K derived: sum of 2 quarters · filed 2012-02-27 | $20.00K 10-K · filed 2012-02-27 | |
| 2009-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $14.00K 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $7.00K 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $1.59M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |